OBJECTIVE: To review systematically the published literature on the treatment of deep venous thromboembolism after spinal cord injury (SCI). DATA SOURCES: MEDLINE/PubMed, CINAHL, EMBASE, and PsycINFO databases were searched for articles addressing the treatment of deep venous thromboembolism post-SCI. Randomized controlled trials (RCTs) were assessed for methodologic quality using the Physiotherapy Evidence Database Scale, while non-RCTs were assessed using the Downs and Black evaluation tool. STUDY SELECTION: Studies included RCTs, non-RCTS, cohort, case-control, case series, pre-post, and postinterventional studies. Case studies were included only when no other studies were available. DATA EXTRACTION: Data extracted included demographics, the nature of the study intervention, and study results. DATA SYNTHESIS: Levels of evidence were assigned to the interventions using a modified Sackett scale. CONCLUSIONS: Twenty-three studies met inclusion criteria. Thirteen studies examined various pharmacologic interventions for the treatment or prevention of deep venous thrombosis in patients with SCI. There was strong evidence to support the use of low-molecular-weight heparin in reducing venous thrombosis events, and a higher adjusted dose of unfractionated heparin was found to be more effective than 5000 units administered every 12 hours, although bleeding complications were more common. Nonpharmacologic treatments were also reviewed, but again limited evidence was found to support these treatments.
OBJECTIVE: To review systematically the published literature on the treatment of deep venous thromboembolism after spinal cord injury (SCI). DATA SOURCES: MEDLINE/PubMed, CINAHL, EMBASE, and PsycINFO databases were searched for articles addressing the treatment of deep venous thromboembolism post-SCI. Randomized controlled trials (RCTs) were assessed for methodologic quality using the Physiotherapy Evidence Database Scale, while non-RCTs were assessed using the Downs and Black evaluation tool. STUDY SELECTION: Studies included RCTs, non-RCTS, cohort, case-control, case series, pre-post, and postinterventional studies. Case studies were included only when no other studies were available. DATA EXTRACTION: Data extracted included demographics, the nature of the study intervention, and study results. DATA SYNTHESIS: Levels of evidence were assigned to the interventions using a modified Sackett scale. CONCLUSIONS: Twenty-three studies met inclusion criteria. Thirteen studies examined various pharmacologic interventions for the treatment or prevention of deep venous thrombosis in patients with SCI. There was strong evidence to support the use of low-molecular-weight heparin in reducing venous thrombosis events, and a higher adjusted dose of unfractionated heparin was found to be more effective than 5000 units administered every 12 hours, although bleeding complications were more common. Nonpharmacologic treatments were also reviewed, but again limited evidence was found to support these treatments.
Authors: A Cogo; A W Lensing; M M Koopman; F Piovella; S Siragusa; P S Wells; S Villalta; H R Büller; A G Turpie; P Prandoni Journal: BMJ Date: 1998-01-03
Authors: D Green; M Y Lee; A C Lim; J S Chmiel; M Vetter; T Pang; D Chen; L Fenton; G M Yarkony; P R Meyer Journal: Ann Intern Med Date: 1990-10-15 Impact factor: 25.391
Authors: Sara L Hebbeler; Christina M Marciniak; Susan Crandall; David Chen; Steven Nussbaum; Susan Mendelewski Journal: J Spinal Cord Med Date: 2004 Impact factor: 1.985
Authors: Faye Y Chiou-Tan; Hector Garza; Kwai-Tung Chan; Kenneth C Parsons; William H Donovan; Claudia S Robertson; Sally Ann Holmes; Daniel E Graves; Diana H Rintala Journal: Am J Phys Med Rehabil Date: 2003-09 Impact factor: 2.159
Authors: S Matsumoto; K Suda; S Iimoto; K Yasui; M Komatsu; C Ushiku; M Takahata; Y Kobayashi; Y Tojo; K Fujita; A Minami Journal: Spinal Cord Date: 2015-02-03 Impact factor: 2.772
Authors: Magdalena Mackiewicz-Milewska; Stanisław Jung; Andrzej C Kroszczyński; Hanna Mackiewicz-Nartowicz; Zbigniew Serafin; Małgorzata Cisowska-Adamiak; Jerzy Pyskir; Iwona Szymkuć-Bukowska; Wojciech Hagner; Danuta Rość Journal: J Spinal Cord Med Date: 2015-07-01 Impact factor: 1.985
Authors: Michael G Fehlings; Lindsay A Tetreault; Bizhan Aarabi; Paul Anderson; Paul M Arnold; Darrel S Brodke; Anthony S Burns; Kazuhiro Chiba; Joseph R Dettori; Julio C Furlan; Gregory Hawryluk; Langston T Holly; Susan Howley; Tara Jeji; Sukhvinder Kalsi-Ryan; Mark Kotter; Shekar Kurpad; Brian K Kwon; Ralph J Marino; Allan R Martin; Eric Massicotte; Geno Merli; James W Middleton; Hiroaki Nakashima; Narihito Nagoshi; Katherine Palmieri; Anoushka Singh; Andrea C Skelly; Eve C Tsai; Alexander Vaccaro; Jefferson R Wilson; Albert Yee; James S Harrop Journal: Global Spine J Date: 2017-09-05